Archives By Month: February 2018

Good results for the Phase 2 Coversin drug trial (daily injection)

Posted on February 9, 2018

Akari Therapeutics Announces Completion of Phase II COBALT Trial of Coversin in Patients with PNH and Further Progress of Clinical Trials The final three Paroxysmal Nocturnal Hemoglobinuria (PNH) patients enrolled […]

Read more About Good results for the Phase 2 Coversin drug trial (daily injection)